XIAOBIN WU reported sales of ADS (American Depositary Shares). The filing lists three ADS dispositions: 1,357 ADS for $361,996.85 on 06/16/2026, 626 ADS for $163,512.26 on 06/11/2026, and 1,484 ADS for $399,738.11 on 06/08/2026. The form also lists a separate ADS entry of 1,292 ADS tied to Restricted Stock Vesting Under a Registered Plan dated 06/22/2026.
ONC files a Form 144 to sell 3,410 ADS. The filing lists the sale as Restricted Stock Vesting Under a Registered Plan, with the issuer identified as the recipient of the vested ADS on 06/22/2026. The excerpt also reports three recent ADS dispositions by John Oyler: 4,940 ADS on 06/08/2026, 1,949 ADS on 06/11/2026, and 3,693 ADS on 06/16/2026, each showing corresponding gross proceeds.
BeOne Medicines Ltd. President and COO Wu Xiaobin reported an open-market sale of 1,357 American Depositary Shares (ADS) at a weighted average price of $266.7626 per ADS. The footnotes state this sale was mandated by a tax withholding provision tied to the vesting of a restricted share unit (RSU) award previously granted to him.
Each ADS represents 13 ordinary shares. Following the transaction, Wu holds 12,365 ADS directly, 4,000 ADS indirectly through his wife, and 1,290,520 ordinary shares directly, indicating he retains a substantial equity position. The RSU award vests in four equal annual installments on each anniversary of June 15, 2023, with unvested units subject to accelerated vesting upon certain termination events.
BeOne Medicines Ltd. Chief Executive Officer John Oyler reported open‑market sales of 3,693 American Depositary Shares on June 16, 2026. The ADS were sold in three trades at weighted average prices of about $264.87 to $266.69 per ADS.
According to a footnote, these sales were executed under a mandatory tax‑withholding provision tied to the vesting of a restricted share unit award previously granted to him. After these transactions, Oyler directly holds 5,649,640 Ordinary Shares and also reports several indirect Ordinary Share holdings via trusts and an LLC, for some of which he disclaims beneficial ownership.
BeOne Medicines Ltd. executive Henry Lee Chan reported an automated sale of American Depositary Shares to satisfy tax obligations tied to restricted share unit vesting. He sold 590 American Depositary Shares at $265.975 each, representing 13 ordinary shares per ADS, and now directly holds 338,884 Ordinary Shares.
BeOne Medicines Ltd. executive Wang Lai reported a small mandatory share sale tied to equity compensation. On the date shown, he sold 1,169 American Depositary Shares at a weighted average price of $265.3857 per ADS to satisfy tax withholding on a vesting restricted share unit award, rather than as a discretionary trade. Each ADS represents 13 ordinary shares. After these transactions, he continues to hold 1,694,888 ordinary shares directly, while additional ordinary shares are held indirectly through Wang Holdings LLC and an employee RMB share participation plan, for which he disclaims beneficial ownership except for any pecuniary interest.
ONC proposes the sale of 590 ADSs under a registered plan vesting on 06/15/2026. The Form 144 lists the security as ADS and notes the disposition method as "Restricted Stock Vesting Under a Registered Plan." The filing also shows recent ADS dispositions by Chan Lee on 06/11/2026 (428 ADS, $110,267.78) and 06/08/2026 (871 ADS, $235,539.13), plus two trades of 332 ADS each on 05/13/2026 and 04/08/2026 with proceeds of $103,159.04 and $103,447.88.
ONC notice under Rule 144 reporting proposed sales of ADS and recent dispositions by a named holder. The filing lists an intended sale entry for ADS with a 06/15/2026 vesting/registered‑plan notation and two reported dispositions by Lai Wang on 06/08/2026 and 06/11/2026.
The record shows quantities reported next to those dates (1367 and 756) and references NASDAQ. This filing is administrative notice of resale under Rule 144; it does not state price or proceeds.
ONC submitted a Rule 144 notice reporting proposed sales of American Depositary Shares (ADS) by an affiliate. The filing lists a Restricted Stock Vesting Under a Registered Plan for 1,357 ADS on 06/15/2026 and two prior ADS dispositions by Xiaobin Wu on 06/11/2026 (626 ADS) and 06/08/2026 (1,484 ADS), with dollar amounts shown in the excerpt.
Form 144 filing reports ADS dispositions by an affiliate of the issuer. The notice lists ADS as the security type with dates in June 2026 and specific recent dispositions: 1,949 ADS for $501,354.72 on 06/11/2026 and 4,940 ADS for $1,336,547.63 on 06/08/2026. The filing also references a restricted stock vesting under a registered plan dated 06/15/2026.